These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7126116)

  • 1. Patterns of psychophysiological change in the treatment of agoraphobia.
    Mavissakalian M; Michelson L
    Behav Res Ther; 1982; 20(4):347-56. PubMed ID: 7126116
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic utility of Locus of Control in treatment of agoraphobia.
    Michelson L; Mavissakalian M; Meminger S
    Behav Res Ther; 1983; 21(3):309-13. PubMed ID: 6615395
    [No Abstract]   [Full Text] [Related]  

  • 3. Psychophysiological outcome of behavioral and pharmacological treatments of agoraphobia.
    Michelson L; Mavissakalian M
    J Consult Clin Psychol; 1985 Apr; 53(2):229-36. PubMed ID: 3998250
    [No Abstract]   [Full Text] [Related]  

  • 4. Two-year follow-up of exposure and imipramine treatment of agoraphobia.
    Mavissakalian M; Michelson L
    Am J Psychiatry; 1986 Sep; 143(9):1106-12. PubMed ID: 3529993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined pharmacological and behavioral treatment for agoraphobia.
    Telch MJ; Agras WS; Taylor CB; Roth WT; Gallen CC
    Behav Res Ther; 1985; 23(3):325-35. PubMed ID: 2860892
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential effects of imipramine and behavior therapy on panic disorder with agoraphobia.
    Mavissakalian M
    Psychopharmacol Bull; 1989; 25(1):27-9. PubMed ID: 2672069
    [No Abstract]   [Full Text] [Related]  

  • 7. Agoraphobia: the 'what if' syndrome.
    Fier M
    J Med Soc N J; 1981 Apr; 78(4):286-8. PubMed ID: 6939897
    [No Abstract]   [Full Text] [Related]  

  • 8. Agoraphobia: relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine.
    Mavissakalian M; Michelson L
    J Clin Psychiatry; 1986 Mar; 47(3):117-22. PubMed ID: 3512534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure and communications training in the treatment of agoraphobia.
    Chambless DL; Foa EB; Groves GA; Goldstein AJ
    Behav Res Ther; 1982; 20(3):219-31. PubMed ID: 7092765
    [No Abstract]   [Full Text] [Related]  

  • 10. Cognitive and behavioral treatments of agoraphobia: clinical, behavioral, and psychophysiological outcomes.
    Michelson L; Mavissakalian M; Marchione K
    J Consult Clin Psychol; 1985 Dec; 53(6):913-25. PubMed ID: 3910681
    [No Abstract]   [Full Text] [Related]  

  • 11. Autonomic changes after treatment of agoraphobia with panic attacks.
    Roth WT; Telch MJ; Taylor CB; Agras WS
    Psychiatry Res; 1988 Apr; 24(1):95-107. PubMed ID: 3393620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obsessive-compulsive symptoms in agoraphobia: changes with treatment.
    Fava GA; Zielezny M; Luria E; Canestrari R
    Psychiatry Res; 1988 Jan; 23(1):57-63. PubMed ID: 3363016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synchrony and desynchrony in high and low arousal subjects undergoing therapeutic exposure.
    Gerew AB; Romney DM; Leboeuf A
    J Behav Ther Exp Psychiatry; 1989 Mar; 20(1):41-8. PubMed ID: 2570083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agoraphobia: a multimodal treatment approach.
    Schwartz LS; Val ER
    Am J Psychother; 1984 Jan; 38(1):35-46. PubMed ID: 6711708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically significant improvement in agoraphobia research.
    Mavissakalian M
    Behav Res Ther; 1986; 24(3):369-70. PubMed ID: 2873811
    [No Abstract]   [Full Text] [Related]  

  • 16. Imipramine with or without cognitive-behavior therapy in the treatment of an agoraphobic.
    Last CG; Barlow DH; O'Brien GT
    Psychol Rep; 1983 Aug; 53(1):103-14. PubMed ID: 6635054
    [No Abstract]   [Full Text] [Related]  

  • 17. How do desynchronous response systems relate to the treatment of agoraphobia: a follow-up evaluation.
    Craske MG; Sanderson WC; Barlow DH
    Behav Res Ther; 1987; 25(2):117-22. PubMed ID: 3593164
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of agoraphobia: triple response measurement.
    Himadi WG; Boice R; Barlow DH
    Behav Res Ther; 1985; 23(3):311-23. PubMed ID: 4004712
    [No Abstract]   [Full Text] [Related]  

  • 19. Paradoxical intention in the treatment of agoraphobia and other anxiety disorders.
    Michelson L; Ascher LM
    J Behav Ther Exp Psychiatry; 1984 Sep; 15(3):215-20. PubMed ID: 6490931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agoraphobia.
    Horn TL
    Am Fam Physician; 1985 Jul; 32(1):165-73. PubMed ID: 2861737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.